Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor
Launched by STANFORD UNIVERSITY · Feb 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving stroke patients a free home blood pressure monitor, along with some training, can help them manage their high blood pressure better. The researchers want to find out if this device not only helps improve blood pressure control for all patients but also if it is especially beneficial for those who may have less access to healthcare resources. They will also see if better management of blood pressure can lead to fewer health problems for these patients.
To participate, you need to be at least 18 years old and have been admitted to Stanford Hospital for a stroke-related issue. You should have high blood pressure and not already have a working blood pressure monitor at home. If you join, you'll be asked to take your blood pressure at home and keep track of the results, and you'll receive follow-up phone calls from the research team after three and six months. This study is currently recruiting participants of all genders, so if you or a family member are eligible, it might be a good opportunity to improve health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 admitted to the Stanford Hospital (SHC) stroke service and discharging to home or acute rehab
- • Diagnosis of Ischemic Stroke, Hemorrhagic Stroke, transient ischemic attack (TIA), or otherwise deemed to be at increased risk of stroke by the treating team (for example, asymptomatic carotid stenosis).
- • No usable home blood pressure cuff available
- • Diagnosis of hypertension or elevated blood pressure (\> 130/80) concerning to the treating clinician for hypertension
- • Participant or surrogate able to apply a home blood pressure cuff on the participant
- • Patient or Legally Authorized Representative (LAR) agree to participate and are able to consent.
- Exclusion Criteria:
- • Currently enrolled in another blood pressure or secondary prevention interventional research study
- • Upper arm circumference \> 20 inches
- • Any other reason that, in the opinion of the investigator, makes the person a poor candidate for participation in this study
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Liron D Kraler, MD
Principal Investigator
Stanford University
Christina M Mijalski Sells, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials